Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Pers Disord ; 38(1): 19-33, 2024 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-38324247

RESUMO

There is a lack of studies that have prospectively examined adverse childhood experiences (ACEs) in association with a personality disorder (PD). Data from a sample of 8,199 adolescents first assessed for ACEs were linked with subsequent data from the Norwegian Patient Register in order to obtain diagnoses of a PD in adulthood (after a 14-year follow-up). We used logistic regression analysis. Any type of ACE gave a 3.8-fold higher risk of developing a PD. Abuse, more specifically emotional abuse, came out as one of the strongest predictors. Of the adolescents who developed a PD, approximately 90% had a history of ACE. The results of this study support the importance of assessing ACEs, such as abuse, neglect, and household dysfunction, in the diagnostic procedure and treatment for PD.


Assuntos
Experiências Adversas da Infância , Adolescente , Humanos , Criança , Estudos Prospectivos , Estudos Longitudinais , Transtornos da Personalidade
2.
Addict Behav Rep ; 17: 100488, 2023 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-37077505

RESUMO

Aim: To investigate the association of adverse childhood experiences (ACEs) and substance use disorders (alcohol and illicit drug use disorders), specifically by gender, in a large longitudinal non-clinical population study. Methods: Data from 8199 adolescents, first assessed for ACE (2006-2008), were linked with subsequent data from the Norwegian Patient Register to obtain diagnoses of a substance use disorder in adulthood (after 12-14 years' follow-up in March 2020). This study used logistic regression analysis to assess the associations between ACEs and substance use disorders with respect to gender. Results: Adults with any history of ACEs have a 4.3-fold higher likelihood of developing a substance use disorder. Female adults had a 5.9-fold higher likelihood of developing an alcohol use disorder. Emotional neglect, sexual abuse and physical abuse were the strongest individual ACE predictors for this association. Male adults had a 5.0-fold higher likelihood of developing an illicit drug use disorder (for example stimulants such as cocaine, inhibiter such as opioids, cannabinoids and multiple drugs). Physical abuse, parental divorce and witnessed violence were the strongest individual ACE predictors for this association. Conclusions: This study reinforces the association between ACEs and substance use disorders and exposes a gender-specific pattern. Increased attention should be paid to the meaning of individual ACEs as well as to the accumulation of ACEs in the development of a substance use disorder.

3.
Soc Psychiatry Psychiatr Epidemiol ; 57(12): 2359-2366, 2022 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-35460058

RESUMO

PURPOSE: Studies of adverse childhood experiences (ACEs) undertaken at the time of adolescence in the general population are not common. The aim of this study was to determine the prevalence and co-occurrence of the individual ACEs and sub-types of ACEs in a large population of adolescents. METHODS: Data were used from the Young Nord-Trøndelag Health (Young HUNT 3) study, a population-based study of young adolescents. ACEs were operational defined as sexual, physical and/or emotional abuse; physical and/or emotional neglect; and/or household dysfunction. Co-occurrence was measured as the accumulation of ACEs and as an overlap analysis. RESULTS: Of the 8199 evaluable adolescents, 65.8% had experienced at least one ACE and 28% of those had experienced more than one ACE. Household dysfunction was the most prevalent ACE subtype. The biggest overlaps among the three ACE sub-types were seen in those reporting neglect or abuse. CONCLUSION: There was a high degree of overlap between the three ACE sub-types and the individual ACEs, indicating that ACEs should be assessed together as a whole rather than separately. This study provides an opportunity to assess ACEs and their co-occurrences in relation to outcomes later in life.


Assuntos
Experiências Adversas da Infância , Maus-Tratos Infantis , Criança , Adolescente , Humanos , Prevalência , Maus-Tratos Infantis/psicologia , Características da Família
5.
J Affect Disord ; 175: 351-8, 2015 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-25665495

RESUMO

BACKGROUND: Dispositional optimism, a personality trait characterized by generalized positive expectations towards the future, is thought to remain rather stable over time. It is however largely unknown to what extent affective disorders and its risk factors affect dispositional optimism. METHODS: We examined the association between (lifetime) affective disorders and childhood trauma with dispositional optimism in a sample of 2104 subjects (aged 18-65 years) from the Netherlands Study of Depression and Anxiety (NESDA). Dispositional optimism was measured with the Life Orientation Test Revised (LOT-R). Diagnoses of depressive and anxiety disorders were based on the Composite Interview diagnostic Instrument (CIDI).Childhood trauma was assessed using the Childhood Trauma Interview (CTI) and life-events with the List of Threatening Events Questionnaire (LTQ). RESULTS: The 2104 participants were on average 46.0 (SD 13.1) years old and 65.8% were female. Multivariate analyses showed that dispositional optimism was inversely associated with current affective disorders (depression: B=-1.089 and anxiety: B=-1.066, both p<0.001), but also with remitted affective disorders (depression: B=-0.822 and anxiety: B=-0.558, both p<0.001) and severity of depression (B=-4.230; p<0.001). A history of childhood emotional maltreatment (B=-0.905, p<0.001) was related to lower optimism, whilst positive life-events were associated with higher levels of optimism (B=0.235, p>0.001). LIMITATIONS: The cross-sectional design hampers inferences about causality. CONCLUSION: Lower levels of dispositional optimism are associated with stage of affective disorders, even after remission, and a history of childhood emotional maltreatment. Identification of the risk factors contributes to understand fluctuations in dispositional optimism.


Assuntos
Transtornos de Ansiedade/psicologia , Ansiedade/psicologia , Depressão/psicologia , Transtorno Depressivo/psicologia , Transtornos do Humor/psicologia , Personalidade , Adulto , Afeto , Idoso , Estudos Transversais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Países Baixos , Fatores de Risco , Inquéritos e Questionários
6.
Gen Hosp Psychiatry ; 34(2): 209.e1-3, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-21872335

RESUMO

BACKGROUND: Highly potent dopamine D(2) receptor antagonistic antipsychotics may induce hyperprolactinemia. Conversely, drugs for the treatment of prolactinoma may activate dopamine D2 receptors, which can induce or aggravate psychosis. Aripiprazole, as a partial D(2) receptor agonist, may be the drug of choice in patients suffering from both psychosis and prolactinoma. OBJECTIVE: We evaluated the effects of aripiprazole on the size of a cystic macroadenoma by magnetic resonance imaging and on prolactin levels in a patient suffering from psychosis and prolactinoma. METHOD: This is a case report of a 53-year-old female patient with a chronic psychotic disorder and moderate mental retardation who had developed a prolactinoma that was resected but still had residual adenoma and hyperprolactinemia. Antipsychotic medication was switched from risperidone to aripiprazole before a dopamine agonist was initiated. RESULTS: After change in treatment, there were reductions in serum prolactin levels, tumor size and visual field defects. We observed no psychotic decompensation. CONCLUSION: The combination of aripiprazole and quinagolide could be considered as an effective treatment in patients suffering from both psychosis and a prolactinoma.


Assuntos
Aminoquinolinas/farmacologia , Antipsicóticos/farmacologia , Agonistas de Dopamina/farmacologia , Quimioterapia Combinada , Piperazinas/farmacologia , Neoplasias Hipofisárias/tratamento farmacológico , Prolactina/efeitos dos fármacos , Prolactinoma/tratamento farmacológico , Transtornos Psicóticos/complicações , Quinolonas/farmacologia , Aminoquinolinas/uso terapêutico , Antipsicóticos/uso terapêutico , Aripiprazol , Doença Crônica , Agonistas de Dopamina/uso terapêutico , Feminino , Humanos , Pessoa de Meia-Idade , Países Baixos , Piperazinas/uso terapêutico , Neoplasias Hipofisárias/complicações , Prolactina/sangue , Quinolonas/uso terapêutico , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...